Global Human Papillomavirus Vaccine (Types 16, 18) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Human papillomavirus vaccine (16, 18 types) is a vaccine that can prevent 16, 18 types of human papillomavirus infection. Prophylactic HPV vaccination can effectively reduce 16, 18 types of human papillomavirus infection and related clinical diseases. Inoculation of human papillomavirus vaccines (types 16 and 18) can stimulate the body to produce neutralizing antibodies. When human papillomavirus invades the human body, the neutralizing antibodies can recognize the virus and bind to it, clear the virus through neutralization, and prevent organ failure. Neck cancer, penile cancer, vulvar cancer, oropharyngeal cancer, reproductive Shen and other diseases caused by human papillomavirus infection.
Human Papillomavirus Vaccine (Types 16, 18) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Papillomavirus Vaccine (Types 16, 18) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from 9-26 Years Old and 26-45 Years Old are the major drivers for the industry.
Human papillomavirus vaccine (types 16, 18) is a preventive vaccine that can effectively prevent HPV infection, thereby preventing cervical cancer and other HPV-related cancers. The prevention and treatment of cervical cancer and other HPV-related cancers have undergone major advances due to the development of human papillomavirus vaccines (types 16, 18). The development of human papillomavirus vaccines (types 16, 18) has received global attention and many countries have included it in their national immunization programmes. Over the past few years, the human papillomavirus vaccine (types 16, 18) has achieved great success, and the incidence of cervical cancer and other HPV-related cancers has decreased significantly worldwide. As the HPV vaccine becomes more widely available, its prospects are very promising. Global HPV vaccination rates are expected to increase further and the incidence of cervical cancer and other HPV-related cancers to continue to decline in the coming years. In addition, the development of human papillomavirus vaccines (types 16, 18) will bring additional social and economic benefits, including reducing medical expenditures and improving public health.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Papillomavirus Vaccine (Types 16, 18) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
GlaxoSmithKline
Merck & Co., Inc.
Serum Institute of India
INNOVAX
ZSSW
HUMANWELL HEALTHCARE
WALVAX
Segment by Type
HPV16
HPV18
Segment by Application
9-26 Years Old
26-45 Years Old
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Human Papillomavirus Vaccine (Types 16, 18) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Papillomavirus Vaccine (Types 16, 18), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Papillomavirus Vaccine (Types 16, 18) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Human Papillomavirus Vaccine (Types 16, 18) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Papillomavirus Vaccine (Types 16, 18) introduction, etc. Human Papillomavirus Vaccine (Types 16, 18) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Human Papillomavirus Vaccine (Types 16, 18) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Table of Content
1 Human Papillomavirus Vaccine (Types 16, 18) Market Overview
1.1 Human Papillomavirus Vaccine (Types 16, 18) Product Overview
1.2 Human Papillomavirus Vaccine (Types 16, 18) Market Segment by Type
1.2.1 HPV16
1.2.2 HPV18
1.3 Global Human Papillomavirus Vaccine (Types 16, 18) Market Size by Type
1.3.1 Global Human Papillomavirus Vaccine (Types 16, 18) Market Size Overview by Type (2018-2029)
1.3.2 Global Human Papillomavirus Vaccine (Types 16, 18) Historic Market Size Review by Type (2018-2024)
1.3.3 Global Human Papillomavirus Vaccine (Types 16, 18) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Papillomavirus Vaccine (Types 16, 18) Sales Breakdown by Type (2018-2024)
1.4.2 Europe Human Papillomavirus Vaccine (Types 16, 18) Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales Breakdown by Type (2018-2024)
2 Global Human Papillomavirus Vaccine (Types 16, 18) Market Competition by Company
2.1 Global Top Players by Human Papillomavirus Vaccine (Types 16, 18) Sales (2018-2024)
2.2 Global Top Players by Human Papillomavirus Vaccine (Types 16, 18) Revenue (2018-2024)
2.3 Global Top Players by Human Papillomavirus Vaccine (Types 16, 18) Price (2018-2024)
2.4 Global Top Manufacturers Human Papillomavirus Vaccine (Types 16, 18) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Papillomavirus Vaccine (Types 16, 18) Market Competitive Situation and Trends
2.5.1 Human Papillomavirus Vaccine (Types 16, 18) Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Papillomavirus Vaccine (Types 16, 18) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Papillomavirus Vaccine (Types 16, 18) as of 2022)
2.7 Date of Key Manufacturers Enter into Human Papillomavirus Vaccine (Types 16, 18) Market
2.8 Key Manufacturers Human Papillomavirus Vaccine (Types 16, 18) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Papillomavirus Vaccine (Types 16, 18) Status and Outlook by Region
3.1 Global Human Papillomavirus Vaccine (Types 16, 18) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Human Papillomavirus Vaccine (Types 16, 18) Historic Market Size by Region
3.2.1 Global Human Papillomavirus Vaccine (Types 16, 18) Sales in Volume by Region (2018-2024)
3.2.2 Global Human Papillomavirus Vaccine (Types 16, 18) Sales in Value by Region (2018-2024)
3.2.3 Global Human Papillomavirus Vaccine (Types 16, 18) Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Human Papillomavirus Vaccine (Types 16, 18) Forecasted Market Size by Region
3.3.1 Global Human Papillomavirus Vaccine (Types 16, 18) Sales in Volume by Region (2024-2029)
3.3.2 Global Human Papillomavirus Vaccine (Types 16, 18) Sales in Value by Region (2024-2029)
3.3.3 Global Human Papillomavirus Vaccine (Types 16, 18) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Human Papillomavirus Vaccine (Types 16, 18) by Application
4.1 Human Papillomavirus Vaccine (Types 16, 18) Market Segment by Application
4.1.1 9-26 Years Old
4.1.2 26-45 Years Old
4.2 Global Human Papillomavirus Vaccine (Types 16, 18) Market Size by Application
4.2.1 Global Human Papillomavirus Vaccine (Types 16, 18) Market Size Overview by Application (2018-2029)
4.2.2 Global Human Papillomavirus Vaccine (Types 16, 18) Historic Market Size Review by Application (2018-2024)
4.2.3 Global Human Papillomavirus Vaccine (Types 16, 18) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Papillomavirus Vaccine (Types 16, 18) Sales Breakdown by Application (2018-2024)
4.3.2 Europe Human Papillomavirus Vaccine (Types 16, 18) Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales Breakdown by Application (2018-2024)
5 North America Human Papillomavirus Vaccine (Types 16, 18) by Country
5.1 North America Human Papillomavirus Vaccine (Types 16, 18) Historic Market Size by Country
5.1.1 North America Human Papillomavirus Vaccine (Types 16, 18) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Human Papillomavirus Vaccine (Types 16, 18) Sales in Volume by Country (2018-2024)
5.1.3 North America Human Papillomavirus Vaccine (Types 16, 18) Sales in Value by Country (2018-2024)
5.2 North America Human Papillomavirus Vaccine (Types 16, 18) Forecasted Market Size by Country
5.2.1 North America Human Papillomavirus Vaccine (Types 16, 18) Sales in Volume by Country (2024-2029)
5.2.2 North America Human Papillomavirus Vaccine (Types 16, 18) Sales in Value by Country (2024-2029)
6 Europe Human Papillomavirus Vaccine (Types 16, 18) by Country
6.1 Europe Human Papillomavirus Vaccine (Types 16, 18) Historic Market Size by Country
6.1.1 Europe Human Papillomavirus Vaccine (Types 16, 18) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Human Papillomavirus Vaccine (Types 16, 18) Sales in Volume by Country (2018-2024)
6.1.3 Europe Human Papillomavirus Vaccine (Types 16, 18) Sales in Value by Country (2018-2024)
6.2 Europe Human Papillomavirus Vaccine (Types 16, 18) Forecasted Market Size by Country
6.2.1 Europe Human Papillomavirus Vaccine (Types 16, 18) Sales in Volume by Country (2024-2029)
6.2.2 Europe Human Papillomavirus Vaccine (Types 16, 18) Sales in Value by Country (2024-2029)
7 Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) by Region
7.1 Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Historic Market Size by Region
7.1.1 Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales in Value by Region (2024-2029)
8 Latin America Human Papillomavirus Vaccine (Types 16, 18) by Country
8.1 Latin America Human Papillomavirus Vaccine (Types 16, 18) Historic Market Size by Country
8.1.1 Latin America Human Papillomavirus Vaccine (Types 16, 18) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales in Volume by Country (2018-2024)
8.1.3 Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales in Value by Country (2018-2024)
8.2 Latin America Human Papillomavirus Vaccine (Types 16, 18) Forecasted Market Size by Country
8.2.1 Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales in Value by Country (2024-2029)
9 Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) by Country
9.1 Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Historic Market Size by Country
9.1.1 Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Human Papillomavirus Vaccine (Types 16, 18) Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GlaxoSmithKline Human Papillomavirus Vaccine (Types 16, 18) Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Merck & Co., Inc.
10.2.1 Merck & Co., Inc. Company Information
10.2.2 Merck & Co., Inc. Introduction and Business Overview
10.2.3 Merck & Co., Inc. Human Papillomavirus Vaccine (Types 16, 18) Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck & Co., Inc. Human Papillomavirus Vaccine (Types 16, 18) Products Offered
10.2.5 Merck & Co., Inc. Recent Development
10.3 Serum Institute of India
10.3.1 Serum Institute of India Company Information
10.3.2 Serum Institute of India Introduction and Business Overview
10.3.3 Serum Institute of India Human Papillomavirus Vaccine (Types 16, 18) Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Serum Institute of India Human Papillomavirus Vaccine (Types 16, 18) Products Offered
10.3.5 Serum Institute of India Recent Development
10.4 INNOVAX
10.4.1 INNOVAX Company Information
10.4.2 INNOVAX Introduction and Business Overview
10.4.3 INNOVAX Human Papillomavirus Vaccine (Types 16, 18) Sales, Revenue and Gross Margin (2018-2024)
10.4.4 INNOVAX Human Papillomavirus Vaccine (Types 16, 18) Products Offered
10.4.5 INNOVAX Recent Development
10.5 ZSSW
10.5.1 ZSSW Company Information
10.5.2 ZSSW Introduction and Business Overview
10.5.3 ZSSW Human Papillomavirus Vaccine (Types 16, 18) Sales, Revenue and Gross Margin (2018-2024)
10.5.4 ZSSW Human Papillomavirus Vaccine (Types 16, 18) Products Offered
10.5.5 ZSSW Recent Development
10.6 HUMANWELL HEALTHCARE
10.6.1 HUMANWELL HEALTHCARE Company Information
10.6.2 HUMANWELL HEALTHCARE Introduction and Business Overview
10.6.3 HUMANWELL HEALTHCARE Human Papillomavirus Vaccine (Types 16, 18) Sales, Revenue and Gross Margin (2018-2024)
10.6.4 HUMANWELL HEALTHCARE Human Papillomavirus Vaccine (Types 16, 18) Products Offered
10.6.5 HUMANWELL HEALTHCARE Recent Development
10.7 WALVAX
10.7.1 WALVAX Company Information
10.7.2 WALVAX Introduction and Business Overview
10.7.3 WALVAX Human Papillomavirus Vaccine (Types 16, 18) Sales, Revenue and Gross Margin (2018-2024)
10.7.4 WALVAX Human Papillomavirus Vaccine (Types 16, 18) Products Offered
10.7.5 WALVAX Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Papillomavirus Vaccine (Types 16, 18) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Papillomavirus Vaccine (Types 16, 18) Industrial Chain Analysis
11.4 Human Papillomavirus Vaccine (Types 16, 18) Market Dynamics
11.4.1 Human Papillomavirus Vaccine (Types 16, 18) Industry Trends
11.4.2 Human Papillomavirus Vaccine (Types 16, 18) Market Drivers
11.4.3 Human Papillomavirus Vaccine (Types 16, 18) Market Challenges
11.4.4 Human Papillomavirus Vaccine (Types 16, 18) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Papillomavirus Vaccine (Types 16, 18) Distributors
12.3 Human Papillomavirus Vaccine (Types 16, 18) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Figure
List of Tables
Table 1. Major Company of HPV16
Table 2. Major Company of HPV18
Table 3. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Type (2018-2024) & (K Units)
Table 5. Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Type (2018-2024) & (US& Million)
Table 7. Global Human Papillomavirus Vaccine (Types 16, 18) Market Share in Value by Type (2018-2024)
Table 8. Global Human Papillomavirus Vaccine (Types 16, 18) Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Type (2024-2029) & (K Units)
Table 10. Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Type (2024-2029)
Table 13. Global Human Papillomavirus Vaccine (Types 16, 18) Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Human Papillomavirus Vaccine (Types 16, 18) Sales by Type (2018-2024) & (K Units)
Table 15. North America Human Papillomavirus Vaccine (Types 16, 18) Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units) by Type (2018-2024)
Table 17. Europe Human Papillomavirus Vaccine (Types 16, 18) Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units) by Type (2018-2024)
Table 21. Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Company (2018-2024) & (K Units)
Table 25. Global Human Papillomavirus Vaccine (Types 16, 18) Sales Share by Company (2018-2024)
Table 26. Global Human Papillomavirus Vaccine (Types 16, 18) Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Human Papillomavirus Vaccine (Types 16, 18) Revenue Share by Company (2018-2024)
Table 28. Global Market Human Papillomavirus Vaccine (Types 16, 18) Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Human Papillomavirus Vaccine (Types 16, 18) Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Human Papillomavirus Vaccine (Types 16, 18) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Papillomavirus Vaccine (Types 16, 18) as of 2022)
Table 32. Date of Key Manufacturers Enter into Human Papillomavirus Vaccine (Types 16, 18) Market
Table 33. Key Manufacturers Human Papillomavirus Vaccine (Types 16, 18) Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Human Papillomavirus Vaccine (Types 16, 18) Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Region (2018-2024) & (K Units)
Table 37. Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Region (2018-2024)
Table 40. Global Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Region (2024-2029) & (K Units)
Table 42. Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Region (2024-2029)
Table 45. Global Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Application (2018-2024) & (K Units)
Table 48. Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Application (2018-2024)
Table 51. Global Human Papillomavirus Vaccine (Types 16, 18) Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Application (2024-2029) & (K Units)
Table 53. Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Application (2024-2029)
Table 56. Global Human Papillomavirus Vaccine (Types 16, 18) Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Human Papillomavirus Vaccine (Types 16, 18) Sales by Application (2018-2024) (K Units)
Table 58. North America Human Papillomavirus Vaccine (Types 16, 18) Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Human Papillomavirus Vaccine (Types 16, 18) Sales by Application (2018-2024) (K Units)
Table 60. Europe Human Papillomavirus Vaccine (Types 16, 18) Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales by Application (2018-2024) (K Units)
Table 64. Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Human Papillomavirus Vaccine (Types 16, 18) Sales by Country (2018-2024) & (K Units)
Table 68. North America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Human Papillomavirus Vaccine (Types 16, 18) Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Country (2018-2024)
Table 71. North America Human Papillomavirus Vaccine (Types 16, 18) Sales by Country (2024-2029) & (K Units)
Table 72. North America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Human Papillomavirus Vaccine (Types 16, 18) Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Human Papillomavirus Vaccine (Types 16, 18) Sales by Country (2018-2024) & (K Units)
Table 76. Europe Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Human Papillomavirus Vaccine (Types 16, 18) Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Human Papillomavirus Vaccine (Types 16, 18) Sales by Country (2024-2029) & (K Units)
Table 80. Europe Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Human Papillomavirus Vaccine (Types 16, 18) Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Country (2024-2029)
Table 107. GlaxoSmithKline Company Information
Table 108. GlaxoSmithKline Introduction and Business Overview
Table 109. GlaxoSmithKline Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. GlaxoSmithKline Human Papillomavirus Vaccine (Types 16, 18) Product
Table 111. GlaxoSmithKline Recent Development
Table 112. Merck & Co., Inc. Company Information
Table 113. Merck & Co., Inc. Introduction and Business Overview
Table 114. Merck & Co., Inc. Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Merck & Co., Inc. Human Papillomavirus Vaccine (Types 16, 18) Product
Table 116. Merck & Co., Inc. Recent Development
Table 117. Serum Institute of India Company Information
Table 118. Serum Institute of India Introduction and Business Overview
Table 119. Serum Institute of India Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Serum Institute of India Human Papillomavirus Vaccine (Types 16, 18) Product
Table 121. Serum Institute of India Recent Development
Table 122. INNOVAX Company Information
Table 123. INNOVAX Introduction and Business Overview
Table 124. INNOVAX Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. INNOVAX Human Papillomavirus Vaccine (Types 16, 18) Product
Table 126. INNOVAX Recent Development
Table 127. ZSSW Company Information
Table 128. ZSSW Introduction and Business Overview
Table 129. ZSSW Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. ZSSW Human Papillomavirus Vaccine (Types 16, 18) Product
Table 131. ZSSW Recent Development
Table 132. HUMANWELL HEALTHCARE Company Information
Table 133. HUMANWELL HEALTHCARE Introduction and Business Overview
Table 134. HUMANWELL HEALTHCARE Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. HUMANWELL HEALTHCARE Human Papillomavirus Vaccine (Types 16, 18) Product
Table 136. HUMANWELL HEALTHCARE Recent Development
Table 137. WALVAX Company Information
Table 138. WALVAX Introduction and Business Overview
Table 139. WALVAX Human Papillomavirus Vaccine (Types 16, 18) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. WALVAX Human Papillomavirus Vaccine (Types 16, 18) Product
Table 141. WALVAX Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Human Papillomavirus Vaccine (Types 16, 18) Market Trends
Table 145. Human Papillomavirus Vaccine (Types 16, 18) Market Drivers
Table 146. Human Papillomavirus Vaccine (Types 16, 18) Market Challenges
Table 147. Human Papillomavirus Vaccine (Types 16, 18) Market Restraints
Table 148. Human Papillomavirus Vaccine (Types 16, 18) Distributors List
Table 149. Human Papillomavirus Vaccine (Types 16, 18) Downstream Customers
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Papillomavirus Vaccine (Types 16, 18) Product Picture
Figure 2. Global Human Papillomavirus Vaccine (Types 16, 18) Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Human Papillomavirus Vaccine (Types 16, 18) Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Human Papillomavirus Vaccine (Types 16, 18) Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of HPV16
Figure 6. Global HPV16 Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of HPV18
Figure 8. Global HPV18 Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share by Type in 2022 & 2029
Figure 11. North America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Type in 2022
Figure 12. North America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Type in 2022
Figure 13. Europe Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Type in 2022
Figure 14. Europe Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Type in 2022
Figure 17. Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Papillomavirus Vaccine (Types 16, 18) Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Papillomavirus Vaccine (Types 16, 18) Revenue in 2022
Figure 23. Human Papillomavirus Vaccine (Types 16, 18) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of 9-26 Years Old
Figure 25. Global 9-26 Years Old Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of 26-45 Years Old
Figure 27. Global 26-45 Years Old Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Global Human Papillomavirus Vaccine (Types 16, 18) Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share by Application in 2022 & 2029
Figure 30. North America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Application in 2022
Figure 31. North America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Application in 2022
Figure 32. Europe Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Application in 2022
Figure 33. Europe Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Application in 2022
Figure 36. Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Human Papillomavirus Vaccine (Types 16, 18) Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Human Papillomavirus Vaccine (Types 16, 18) Manufacturing Cost Structure
Figure 41. Human Papillomavirus Vaccine (Types 16, 18) Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices